Literature DB >> 12414113

Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-D-aspartate receptor.

Mark A Prendergast1, D Trent Rogers, Patrick J Mulholland, John M Littleton, Lincoln H Wilkins, Rachel L Self, Avindra Nath.   

Abstract

Human immunodeficiency virus type-I (HIV-1) infection is often associated with neuronal loss in cortical and subcortical regions that may manifest as motor dysfunction and dementia. The function of the HIV-1 transcription protein Tat and subsequent activation of N-methyl-D-aspartate receptors (NMDAr) have been implicated in this form of neurodegeneration. However, it is unclear if Tat interacts directly with the NMDAr and the role of specific NMDAr subunit composition in mediating effects of Tat is also unclear. The present studies examined the ability of HIV-1 Tat1-72 protein (10 pM-1.0 microM) to displace [3H]MK-801 binding and to attenuate spermidine-induced potentiation of this binding in rat brain homogenate comprised of cerebellum, hippocampus, and cerebral cortex. The role of NMDAr polyamine-site function in the neurotoxic effects of Tat was determined using organotypic hippocampal slice cultures. Binding of [3H]MK-801 in adult rat brain homogenate was not reduced by Tat at concentrations below 1 microM. Tat potently inhibited the potentiation of [3H]MK-801 binding produced by co-exposure of membranes to the NMDAr co-agonist spermidine (IC(50)=3.74 nM). In hippocampal explants, Tat produced neurotoxicity in the CA3 and CA1 pyramidal cell layers, as well as in the dentate gyrus, that was significantly reduced by co-exposure to MK-801 (20 microM) and the NMDAr polyamine-site antagonist arcaine (10 microM). Exposure to the HIV-1 Tat deletion mutant (Tatdelta31-61) did not produce neurotoxicity in hippocampal explants. These data suggest that the neurotoxic effects of HIV-1 Tat are mediated, in part, by direct interactions with a polyamine-sensitive site on the NMDAr that positively modulates the function of this receptor. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414113     DOI: 10.1016/s0006-8993(02)03360-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  35 in total

Review 1.  Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport.

Authors:  Italo Mocchetti; Alessia Bachis; Valeriya Avdoshina
Journal:  Neurotox Res       Date:  2011-09-27       Impact factor: 3.911

2.  HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs.

Authors:  J Robert Chang; Ruma Mukerjee; Asen Bagashev; Luis Del Valle; Tinatin Chabrashvili; Brian J Hawkins; Johnny J He; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

3.  HIV-1 Tat-mediated induction of platelet-derived growth factor in astrocytes: role of early growth response gene 1.

Authors:  Crystal Bethel-Brown; Honghong Yao; Shannon Callen; Young Han Lee; Prasanta K Dash; Anil Kumar; Shilpa Buch
Journal:  J Immunol       Date:  2011-03-02       Impact factor: 5.422

4.  Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS.

Authors:  Douglas J Hermes; Changqing Xu; Justin L Poklis; Micah J Niphakis; Benjamin F Cravatt; Ken Mackie; Aron H Lichtman; Bogna M Ignatowska-Jankowska; Sylvia Fitting
Journal:  Neuropharmacology       Date:  2018-08-13       Impact factor: 5.250

Review 5.  Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction.

Authors:  Shilpa Buch; Honghong Yao; Minglei Guo; Tomohisa Mori; Tsung-Ping Su; John Wang
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-16       Impact factor: 4.147

6.  Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders.

Authors:  M Bachani; N Sacktor; J C McArthur; A Nath; J Rumbaugh
Journal:  J Neurovirol       Date:  2013-01-18       Impact factor: 2.643

7.  Intra-accumbal Tat1-72 alters acute and sensitized responses to cocaine.

Authors:  S B Harrod; C F Mactutus; S Fitting; U Hasselrot; R M Booze
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

8.  Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity.

Authors:  Lara Buscemi; David Ramonet; Jonathan D Geiger
Journal:  Neurobiol Dis       Date:  2007-03-20       Impact factor: 5.996

9.  Intra-cornu ammonis 1 administration of the human immunodeficiency virus-1 protein trans-activator of transcription exacerbates the ethanol withdrawal syndrome in rodents and activates N-methyl-D-aspartate glutamate receptors to produce persisting spatial learning deficits.

Authors:  R L Self; K J Smith; T R Butler; J R Pauly; M A Prendergast
Journal:  Neuroscience       Date:  2009-07-18       Impact factor: 3.590

10.  Differences in NMDA receptor expression during human development determine the response of neurons to HIV-tat-mediated neurotoxicity.

Authors:  E A Eugenin; J E King; J E Hazleton; E O Major; M V L Bennett; R S Zukin; Joan W Berman
Journal:  Neurotox Res       Date:  2010-01-22       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.